Letter to the Editor Re: Treatment Progress of Compound Kushen Injection and Gemcitabine in Postoperative Patients with Bladder Cancer and Selection of Drug Delivery Mode.
Arch Esp Urol
; 77(4): 453-454, 2024 May.
Article
in En
| MEDLINE
| ID: mdl-38840292
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
/
Deoxycytidine
/
Gemcitabine
Limits:
Humans
Language:
En
Journal:
Arch Esp Urol
Year:
2024
Document type:
Article
Affiliation country:
China
Country of publication:
Spain